← FDA Drug Approvals (Drugs@FDA)

MONTELUKAST SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2012-08-03

Drug application

FDA Application #

ANDA090926

Application type

Abbreviated New Drug Application (Generic)

Brand name

MONTELUKAST SODIUM

Generic name

Montelukast Sodium

Active ingredients

MONTELUKAST SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

First approval

2012-08-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown